The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Fukuoka, M., Yano, S., Giaccone, G., Tamura, T., Nakagawa, K., Douillard, J.-Y., Nishiwaki, Y., Vansteenkiste, J., Kudoh, S., Rischin, D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.038 · Cited by 2,874
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
Comparative Genomics of the Eukaryotes
Rubin, G. M., Yandell, M. D., Wortman, J. R., Gabor, G. L., Miklos, Nelson, C. R., Hariharan, I. K., Fortini, M. E., Li, P. W., Apweiler, R., et al. (2000) · Science · doi:10.1126/science.287.5461.2204 · Cited by 1,698
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Epidermal growth factor receptor: Mechanisms of activation and signalling
Jorissen, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00098-8 · Cited by 1,565
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
Mendelsohn, J., & Baselga, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.504 · Cited by 1,255
The discovery of receptor tyrosine kinases: targets for cancer therapy
Gschwind, A., Fischer, O. M., & Ullrich, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1360 · Cited by 1,227
The protein tyrosine kinase family of the human genome
Robinson, D. R., Wu, Y.-M., & Lin, S.-F. (2000) · Oncogene · doi:10.1038/sj.onc.1203957 · Cited by 1,167
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick, L. A., Wang, X. Y., Eley, G. D., & James, C. D. (2000) · PubMed · Cited by 740
Phase II Trial of Gefitinib in Recurrent Glioblastoma
Rich, J. N., Reardon, D. A., Peery, T., Dowell, J. M., Quinn, J. A., Penne, K. L., Wikstrand, C. J., Van Duyn, L. B., Dancey, J. E., McLendon, R. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.110 · Cited by 734
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608
Toyooka, S., Maruyama, R., Toyooka, K. O., McLerran, D., Feng, Z., Fukuyama, Y., Virmani, A. K., Zochbauer‐Muller, S., Tsukuda, K., Sugio, K., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10787 · Cited by 288
Self-citationTheTP53 gene, tobacco exposure, and lung cancer
Toyooka, S., Tsuda, T., & Gazdar, A. F. (2003) · Human Mutation · doi:10.1002/humu.10177 · Cited by 276
Self-citationRelationship Between K-ras Oncogene Activation and Smoking in Adenocarcinoma of the Human Lung
Slebos, R. J. C., Hruban, R. H., Dalesio, O., Mooi, W. J., Offerhaus, G. J. A., & Rodenhuis, S. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.14.1024 · Cited by 202
Jänne, P. A., Gurubhagavatula, S., Yeap, B. Y., Lucca, J., Ostler, P., Skarin, A. T., Fidias, P., Lynch, T. J., & Johnson, B. E. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2003.12.014 · Cited by 196
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90232-9 · Cited by 187
Liu, W., Innocenti, F., Chen, P., Das, S., Cook, E. H., & Ratain, M. J. (2003) · PubMed · Cited by 164
Genetics of dark skin in micePreprint
Fitch, K. R., McGowan, K. A., van Raamsdonk, C. D., Fuchs, H., Lee, D., Puech, A., Hérault, Y., Threadgill, D. W., de Angelis, M. H., & Barsh, G. S. (2003) · Genes & Development · doi:10.1101/gad.1023703 · Cited by 146
Fukuyama, Y., Mitsudomi, T., Sugio, K., Ishida, T., Akazawa, K., & Sugimachi, K. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.194 · Cited by 145
RTK mutations and human syndromes
Robertson, S. C., Tynan, J. A., & Donoghue, D. J. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02021-7 · Cited by 143
Cooking oil fumes and risk of lung cancer in women in rural Gansu, China
Metayer, C., Wang, Z., Kleinerman, R. A., Wang, L., Brenner, A. V., Cui, H., Cao, J.-S., & Lubin, J. H. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00412-3 · Cited by 138
p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas, K., Bennett, W. P., Castrén, K., Welsh, J. A., Ma, K., Blömeke, B., Alavanja, M. C. R., & Harris, C. C. (2001) · PubMed · Cited by 128
HER2/neu expression in malignant lung tumors
Hirsch, F. R., Franklin, W. A., Veve, R., Varella‐Garcia, M., & Bunn, P. A. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.31523 · Cited by 102
Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors
Blackledge, G. R. P., & Averbuch, S. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601550 · Cited by 86
A Bull's Eye for Targeted Lung Cancer Therapy
Minna, J. D., Gazdar, A. F., Sprang, S. R., et al. (2004) · Science · doi:10.1126/science.1099578 · Cited by 76
Self-citationAntibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic
Mendelsohn, J. M. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0354-7 · Cited by 64
Transgenic and knock-out mice for deciphering the roles of EGFR ligands
Wong, R. W.-C. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300007 · Cited by 62
Barnes, C. J., & Kumar, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023726827771 · Cited by 34
Cited by
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Self-citationThe T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
Pao, W., Wang, T. Y., Riely, G. J., Miller, V. A., Pan, Q., Ladanyi, M., Zakowski, M. F., Heelan, R. T., Kris, M. G., & Varmus, H. E. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020017 · Cited by 1,516
Yun, C.-H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.017 · Cited by 1,192
Lung cancer in never smokers – A review
Couraud, S., Zalcman, G., Milleron, B., Morin, F., & Souquet, P.-J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.007 · Cited by 960
Metadata
- Authors
- Gazdar, A. F., Shigematsu, H., Herz, J., & Minna, J. D.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 10
- Issue
- 10
- Pages
- 481-486
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2014187999
- Cited by
- 293
- References
- 31
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.